Evidence map›Paper›PMID 32854306›Full record

ArticleInternational journal of molecular sciences2020

Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles.

Michel Boutin, Pamela Lavoie, Iskren Menkovic, Amanda Toupin, Mona Abaoui, Maha Elidrissi-Elawad, Marie-Françoise Arthus, Carole Fortier, Claudia Ménard, Bruno Maranda and 2 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Biomarkers in Rare Diseases.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michel BoutinCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0001-6289-1839
Pamela LavoieCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.
Iskren MenkovicCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0002-8117-2247
Amanda ToupinCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.
Mona AbaouiCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.
Maha Elidrissi-ElawadCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.
Marie-Françoise ArthusCIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, Clinical Research Unit, 5400 Gouin Blvd West, Montreal, QC H4J 1C5, Canada.
Carole FortierCIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, Clinical Research Unit, 5400 Gouin Blvd West, Montreal, QC H4J 1C5, Canada.
Claudia MénardCIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, Clinical Research Unit, 5400 Gouin Blvd West, Montreal, QC H4J 1C5, Canada.
Bruno MarandaCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.
Daniel G BichetCIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, Clinical Research Unit, 5400 Gouin Blvd West, Montreal, QC H4J 1C5, Canada.
Christiane Auray-BlaisCIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Centre de Recherche-CHUS, 3001, 12th Avenue North, Sherbrooke, QC J1H 5N4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the

Indexed as

Adultalpha-GalactosidaseBiomarkersCase-Control StudiesCircadian RhythmDrug Administration ScheduleDrug ChronotherapyEnzyme Replacement TherapyFabry DiseaseFemaleGlycolipidsHumansInfusions, IntravenousMaleSphingolipidsTreatment Outcomealpha-GalactosidaseBiomarkersglobotriaosylceramideglobotriaosyl lysosphingolipidGlycolipidsSphingolipidsTrihexosylceramidesdiurnal variationFabry diseaseglobotriaosylceramideglobotriaosylsphingosineglycosphingolipidsmass spectrometry

Identifiers

PMID32854306
PMCPMC7503492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.